RecruitingPhase 3NCT06612268
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sponsor: Novo Nordisk A/S
Los Angeles, CA · Madera, CA · +47 more sites
Sickle Cell Disease clinical trials in Palo Alto, CA
2 recruiting sickle cell disease studies with a site in Palo Alto, CA.
All trials in Palo Alto, CA · All Sickle Cell Disease trials
RecruitingPhase 1 / Phase 2NCT04819841
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
Sponsor: Kamau Therapeutics
Los Angeles, CA · Palo Alto, CA · +4 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.